Edaravone may exert its neuroprotective effects in ALS by also correcting the abnormal localization of TDP-43, a key ...

What they found was that anyone from between 20 to 39 should be able to swallow around 8.5 times in 30 seconds, those in their 40s should be able to swallow eight times, and those in their 50s should ...

It can be a friend, a very good friend." Margeson, an artist from Marietta, Georgia, is learning how a health care robot ...

NeuroSense Therapeutics, Ltd. , a leading clinical-stage biotechnology company focused on developing treatments for severe neurodegenerative diseases, today announced that two members of its ...

Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show g ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, presented NeuLogiq® ...